HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ming-Hsien Tsai Selected Research

Dementia (Dementias)

11/2021Protective Effects of Angiotensin Receptor Blockers on the Incidence of Dementia in Patients with Chronic Kidney Disease: A Population-Based Nationwide Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ming-Hsien Tsai Research Topics

Disease

37Neoplasms (Cancer)
12/2023 - 05/2007
11Hepatocellular Carcinoma (Hepatoma)
01/2019 - 02/2008
10Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 12/2016
7Squamous Cell Carcinoma of Head and Neck
12/2023 - 01/2018
7Chronic Renal Insufficiency
02/2023 - 03/2016
7Carcinogenesis
03/2021 - 07/2007
6Colorectal Neoplasms (Colorectal Cancer)
01/2018 - 07/2016
5Inflammation (Inflammations)
04/2022 - 12/2011
5Lung Neoplasms (Lung Cancer)
01/2018 - 05/2007
4Infections
01/2022 - 10/2015
4Pneumonia (Pneumonitis)
07/2019 - 09/2013
3Adenocarcinoma of Lung
03/2023 - 02/2009
3Anemia
01/2023 - 03/2016
3Hemorrhage
10/2021 - 01/2012
3Nasopharyngeal Carcinoma
10/2021 - 04/2020
3Breast Neoplasms (Breast Cancer)
10/2018 - 09/2008
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018 - 10/2017
3Lung Diseases (Lung Disease)
01/2017 - 05/2007
2Head and Neck Neoplasms (Head and Neck Cancer)
10/2022 - 01/2018
2Rhinosinusitis
01/2022 - 01/2021
2Nasal Polyps (Nasal Polyp)
01/2022 - 01/2021
2Vascular Diseases (Vascular Disease)
01/2022 - 05/2021
2Hypertension (High Blood Pressure)
01/2021 - 07/2019
2Hyperlipidemias (Hyperlipidemia)
01/2021 - 01/2018
2Adenoma (Adenomas)
07/2020 - 07/2016
2Wounds and Injuries (Trauma)
01/2020 - 03/2019
2Hypoalbuminemia
01/2020 - 01/2018
2Cholangiocarcinoma
12/2018 - 10/2018
2Hypokalemia
01/2018 - 09/2015
2Cytokine Release Syndrome
01/2016 - 01/2016
2Melanoma (Melanoma, Malignant)
11/2015 - 09/2010
2Endocarditis
10/2015 - 04/2015
2Major Depressive Disorder (Major Depressive Disorders)
04/2011 - 04/2010
1Hyperparathyroidism
08/2023
1Extranodal Extension
08/2023
1Body Weight (Weight, Body)
06/2023
1Mouth Neoplasms (Oral Cancer)
04/2023
1Proteinuria
01/2023
1Tinnitus
01/2022
1Sensorineural Hearing Loss
01/2022
1Disease Progression
01/2022

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
01/2022 - 09/2010
5LipidsIBA
06/2023 - 01/2018
5protein phosphatase 5IBA
12/2018 - 01/2017
4AlbuminsIBA
12/2023 - 01/2018
4Hemoglobins (Hemoglobin)IBA
01/2023 - 03/2016
4Particulate MatterIBA
01/2022 - 02/2019
4CytokinesIBA
01/2021 - 01/2016
4tissue-factor-pathway inhibitor 2 (PP5)IBA
12/2018 - 01/2017
4MicellesIBA
01/2018 - 09/2008
4ArsenicIBA
06/2012 - 01/2007
3Fibroblast Growth Factor-23IBA
02/2023 - 03/2016
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 12/2011
3CarcinogensIBA
01/2022 - 07/2016
3PotassiumIBA
07/2020 - 01/2018
3AMP-Activated Protein KinasesIBA
01/2018 - 10/2017
3Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA
10/2017 - 05/2016
3p120 GTPase Activating ProteinIBA
10/2017 - 05/2016
3Zinc OxideFDA Link
01/2017 - 09/2013
3Benzo(a)pyreneIBA
07/2016 - 07/2007
3Sorafenib (BAY 43-9006)FDA Link
05/2016 - 02/2016
3SmokeIBA
06/2012 - 02/2008
2Glucose (Dextrose)FDA LinkGeneric
06/2023 - 01/2019
2Blood Glucose (Blood Sugar)IBA
06/2023 - 01/2022
2SodiumIBA
01/2023 - 07/2020
2Triglycerides (Triacylglycerol)IBA
01/2023 - 01/2022
2Phosphates (Orthophosphate)IBA
01/2023 - 07/2014
2Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA
01/2022 - 01/2017
2Angiotensin Receptor AntagonistsIBA
11/2021 - 01/2021
2Serum AlbuminIBA
01/2020 - 01/2018
2Threonine (L-Threonine)FDA Link
12/2018 - 07/2016
2palbociclibIBA
10/2018 - 01/2017
2oxidized low density lipoproteinIBA
01/2018 - 01/2018
2ErbB Receptors (EGF Receptor)IBA
01/2018 - 07/2016
21-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2018 - 11/2015
2AcidsIBA
09/2015 - 10/2014
2IronIBA
09/2013 - 01/2012
1squamous cell carcinoma-related antigenIBA
04/2023
1CalciumIBA
03/2023
1MineralsIBA
02/2023
1NitrogenIBA
01/2023
1Urea (Carbamide)FDA LinkGeneric
01/2023
1Cetuximab (Erbitux)FDA Link
10/2022
1Alkaline PhosphataseIBA
01/2022

Therapy/Procedure

8Therapeutics
01/2019 - 11/2015
5Renal Dialysis (Hemodialysis)
01/2023 - 02/2015
4Drug Therapy (Chemotherapy)
07/2017 - 09/2008
3Radiotherapy
01/2020 - 01/2018
3Photochemotherapy (Photodynamic Therapy)
01/2018 - 09/2008
2Neck Dissection (Radical Neck Dissection)
08/2022 - 01/2022
2Aftercare (After-Treatment)
01/2022 - 10/2021
2Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
10/2021 - 04/2020
2Free Tissue Flaps
01/2020 - 01/2018
2Catheters
03/2019 - 04/2015
2Precision Medicine
01/2019 - 01/2017
1Adjuvant Chemoradiotherapy
08/2023
1Parathyroidectomy
08/2023
1Kidney Transplantation
08/2023
1Re-Irradiation
10/2022
1Fecal Microbiota Transplantation
04/2022